Table 2.
Comparison of clinical, metabolic and hormonal profile of various pcos phenotypes
| Phenotype A HA1 + OD2 + PCO3 (Mean+SD) (n=111) | Phenotype B HA1 + OD2 (Mean+SD) (n=18) | Phenotype C HA1 + PCO3 (Mean+SD) (n=29) | Phenotype D OD2 + PCO3 (Mean+SD) (n=6) | P | |
|---|---|---|---|---|---|
| Age (in years) | 27.78+3.79 | 27.33+2.93 | 29.59+3.41 | 25.83+4.79 | 0.041* |
| Weight (in kg) | 64.05+10.72 | 59.89+10.50 | 57.65+8.87 | 58.00+11.61 | 0.015* |
| BMI4 (in kg/m2) | 26.99+4.32 | 25.61+3.66 | 23.57+3.41 | 22.58+3.44 | 0.000* |
| Waist circumference (in inches) | 34.04+3.30 | 33.59+4.55 | 32.22+4.27 | 33.00+4.82 | 0.126* |
| Waist-hip ratio | 0.88+0.04 | 0.87+0.04 | 0.86+0.05 | 0.88+0.06 | 0.198* |
| SBP5 in mmHg | 118.00+7.45 | 114.11+7.59 | 117.66+8.07 | 112.67+5.61 | 0.093* |
| DBP6 in mmHg | 75.18+5.75 | 72.78+4.60 | 74.97+5.62 | 71.67+4.08 | 0.126* |
| Ferriman Gallwey Score | 14.68+3.41 | 13.00+3.72 | 12.72+4.32 | 6.17+0.41 | 0.000* |
| Testosterone (nmol/l) | 2.89+1.37 | 2.60+1.01 | 2.44+1.02 | 1.63+0.64 | 0.028# |
| Androstenedione (ng/ml) | 3.16+1.45 | 2.72+0.99 | 2.61+1.14 | 1.90+0.62 | 0.008# |
| Mean Ovarian Volume in cm3 | 13.58+2.69 | 8.42+1.36 | 11.06+2.77 | 12.15+0.87 | 0.000* |
| Mean AFC7 | 12.86+2.89 | 8.75+1.87 | 10.02+2.80 | 10.16+2.78 | 0.000* |
| AMH8 (ng/ml) | 11.34+5.25 | 8.69+3.39 | 9.44+4.53 | 7.76+3.24 | 0.035* |
| OGTT19 (mg/dl) | 91.37+13.13 | 88.17+14.65 | 87.52+11.04 | 86.00+15.88 | 0.370* |
| OGTT210 (mg/dl) | 151.83+35.71 | 143.00+33.76 | 137.41+27.35 | 143.83+56.77 | 0.224* |
| OGTT311 (mg/dl) | 133.09+31.24 | 129.72+25.78 | 122.97+23.47 | 127.67+28.44 | 0.422* |
| Fasting Insulin (mIU/L) | 13.17+6.95 | 9.43+5.67 | 9.19+6.35 | 8.45+2.99 | 0.006* |
| HOMA-IR12 | 3.04+1.87 | 2.17+1.68 | 2.02+1.49 | 1.87+0.97 | 0.012* |
| Serum Triglycerides (mg/dl) | 137.77+51.93 | 120.05+46.80 | 119.49+40.73 | 151.83+76.34 | 0.101# |
| Serum Cholesterol (mg/dl) | 179.37+41.78 | 147.20+39.54 | 157.59+40.40 | 155.50+50.22 | 0.003* |
| LDL13 (mg/dl) | 114.37+24.91 | 102.55+20.03 | 102.47+20.46 | 102.79+19.01 | 0.031* |
| HDL14 (mg/dl) | 45.93+8.59 | 51.08+8.76 | 51.71+8.76 | 51.90+6.50 | 0.002* |
| Baseline FSH15 (IU/l) | 5.60+2.24 | 6.89+3.00 | 6.25+3.09 | 5.12+1.47 | 0.217# |
| Baseline LH16 (IU/l) | 13.37+6.56 | 15.20+6.97 | 13.79+10.39 | 10.01+4.94 | 0.507# |
| LH16:FSH15 | 2.86+1.98 | 2.95+1.95 | 2.34+1.28 | 2.11+1.30 | 0.707* |
| 17 OHP17 (ng/dl) | 1.43+0.79 | 1.02+0.26 | 1.49+0.85 | 0.99+0.21 | 0.059# |
| Vitamin D | 16.77+10.20 | 16.72+7.77 | 16.57+7.75 | 20.34+11.26 | 0.664# |
#Kruskal-wallis, *ANOVA. 1HA: Hyperandrogenism, 2OD: Ovulatory dysfunction, 3PCO: Polycystic ovaries, 4BMI: Body mass index, 5SBP: Systolic blood pressure, 6DBP: Diastolic blood pressure, 7AFC: Antral follicle count, 8AMH: Anti mullerian hormone, 9OGTT1: Oral glucose tolerance test (Fasting), 10OGTT2- Oral glucose tolerance test (1 hour postprandial), 11OGTT1: Oral glucose tolerance test (2 hour postprandial), 12HOMAIR: Homeostatic model assessment insulin resistance, 13LDL: Low density glycoprotein, 14HDL: High density glycoprotein, 15FSH: Follicle stimulating hormone, 16LH: Luteinizing hormone, 1717 OHP: 17-Hydroxyprogesterone